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Introduction
Methamphetamine, a chemical derivative of amphetamine, is a highly addictive
psychostimulant posing an increasing danger to national public health and is the second most
abused illicit drug in the world (Stoneberg, Shukla, and Magness, 2017). Over the past seven
years, methamphetamine use disorder (MUD) has increased in prevalence by between three- and
ten-fold in the United States, depending on demographics (Han et al., 2021). Furthermore,
overdose deaths in the United States attributed to methamphetamine have also tripled in the
second half of the previous decade (Han et al., 2021). While methamphetamine abuse and
overdoses have increased globally, use patterns, addiction behaviors, psychopathology, and
recovery vary widely across demographics— particularly across sexes. For example, Brech et al.
(2004) found that in human females, when compared to males, have an average transition from
initiation to regular use that is one year faster, are five times more likely to start abusing
methamphetamine in order to lose weight, are more likely to suffer from skin and dental
complications because of methamphetamine use, tend to use methamphetamine for longer
consecutive periods of time, and on average require addiction treatment for longer periods of
time (Brecht et al., 2004). In contrast, human men, relative to women, are more likely to report
polydrug use, are more likely to share needles and inject drugs (including methamphetamine),
are more likely to suffer from cardiovascular complications resulting from methamphetamine
use, have higher rates of hallucinations secondary to methamphetamine use, and are more likely
to either steal or manufacture their methamphetamine supply (Brecht et al., 2004). Because the
diagnostic criteria for disordered use of methamphetamine includes resistance to treatment, risky
use behaviors such as needle sharing, and other use patterns that present differentially in men and
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women (5th ed.; DSM–5; American Psychiatric Association, 2013), this information suggests
sex is a biological variable that may contribute to addiction. Despite the abundance of data
exhibiting such differences in human populations, preclinical models exploring the
neuroscientific basis for the sex differences observed in methamphetamine use patterns remains
sparse.
Although many of the addictive mechanisms of methamphetamine remain unknown,
methamphetamine’s addictive properties are partially due to the strong activation of the
mesolimbic dopamine “reward” pathway that the drug induces when first administered in naïve
users (Völlm et al., 2004). This pathway is composed of projections from the ventral tegmental
area to the ventral striatum, orbitofrontal cortex, and anterior cingulate cortex (Golstein and
Volkow, 2002). Upon administration of methamphetamine, transmission of dopamine and other
monoamines rapidly increases in the mesolimbic pathway, while glutamine transmission in this
region decreases (Zhang et al., 2006). Paradoxically, other dopamine pathways— such as the
nigrostriatal pathway— have lower dopaminergic transmission and higher glutamine
transmission with methamphetamine use (Zhang et al., 2006). Emerging research in the field of
addiction has prompted the investigation of pathways outside of these classical models. The
lateral hypothalamus (LH) has known dopaminergic inputs from the ventral tegmental area and
mesolimbic pathway (McGinty et al., 2011), and its role in motivated behaviors has been studied
extensively— with some work predating the discovery of the mesolimbic pathway (Olds, 1958).
The LH, and particularly the orexinergic neurons found within it, is classically associated with
hunger and feeding behaviors, sleep/wake cycling, and endocrine/hormonal functions (Fakhoury
et al., 2020). More recently, the role of the LH in the development of addictive behaviors has
been of interest— particularly due to its connectivity with the mesolimbic pathway (McGinty et
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al., 2011). Research in this area is still emerging and as such there still exists a significant gap in
information regarding the role of the LH in addictive behaviors, particularly with
psychostimulants such as methamphetamine.
As a broad class, the general effects of amphetamines— such as a decrease in appetite,
hypersexuality, changes in locomotion, and vasoconstriction— are due to the way in which
amphetamines increase the concentration of dopamine and other catecholamines in the synapse
(Sulzer et al., 2005). One major target of amphetamines is the dopamine transporter (DAT)
(Sulzer et al., 2005) that is responsible for termination of dopaminergic signaling by packaging
synaptic dopamine molecules into vesicles and moving them back into the presynaptic neuron
(Zhang et al., 2009). Specifically, amphetamines affect DAT activity by forcing reverse
transport, causing the transporter to move dopamine into the synapse— thereby increasing the
available dopamine for transmission (Goodwin et al., 2009). Another key protein involved in the
action of amphetamines, particularly methamphetamine, is the vesicular monoamine transporter
2 (VMAT2). This integral transporter protein is responsible for vesicular packaging and
movement of monoamine neurotransmitters from the presynaptic neuron into the synapse as well
as some synaptic clearance alongside the monoamine transporters such as DAT (Freyberg et al.,
2016). Methamphetamine has distinct binding properties as it relates to VMAT2, such that
inhibition of VMAT proteins will block the behavioral effects of methamphetamine (Freyberg et
al., 2016). The bolstered dopaminergic transmission that occurs following methamphetamine
administration explains the consequential increase in neuronal activity in brain regions receiving
projections from the major dopamine pathways. However, the established dopaminergic
mechanisms of amphetamine class drugs do not explain observed changes in transmission in the
LH when amphetamines are administered— as the LH is composed of orexin, GABA, and
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melanin-concentrating hormone (MCH) neurons (Gompf and Anaclet, 2019). As such, a gap in
knowledge exists on how methamphetamine use may affect activity in the LH, and how these
activity changes may contribute to drug intake behaviors.
As a drug class, amphetamines have wide-reaching effects beyond that of catecholamine
transmission, with widespread impacts on neurophysiology such as neural metabolism,
hemodynamics, and vasoconstriction (Kim et al., 2019). To further understand the effect of
methamphetamine administration on neuronal activity, recent research has turned to
investigating the dynamics of glucose metabolism in the brain. Drug-induced changes to glucose
metabolism in the brain are important to understand as glucose is the preferential energy source
for neurons and glial cells (Mergenthaler et al., 2013), and developing an understanding of
methamphetamine-induced changes in glucose metabolism may provide insights into how
methamphetamine may be affecting cellular activity broadly in the brain. Using enzyme-linked
biosensors and constant potential amperometry, previous studies have investigated the effects of
other psychostimulants on extracellular glucose levels at the second-level timescale. For
example, cocaine has been shown to induce a rapid increase in extracellular glucose
concentrations in the nucleus accumbens (NAc) immediately following injection, followed by a
period of slower changes (Wakabayashi and Kiaytkin, 2015). However, in the substantia nigra
pars reticulata, cocaine injections caused second-scale as well as sustained decreases in
extracellular glucose concentration (Kiyatkin and Lenoir, 2012). Conversely, other stimulants
such as 3,4-methylenedioxypyrovalerone (MDPV) (a synthetic cathinone, or “bath salt”), show
small decreases in extracellular glucose in the NAc over repeated injections (Wakabayashi
2015). These existing studies show the differential changes in glucose delivery that may occur in
different brain regions with different addictive drugs, including amphetamines. Thus, it is
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particularly important to study glucose delivery in novel brain regions that are newly implicated
in a drug’s addictive mechanism.
In addition to a lack of methamphetamine-specific studies as well as biosensing studies in
the LH, previous glucose biosensing studies have neglected to investigate differences between
males and females. Given that significant sex differences have been found in preclinical
investigations of the GLUT3 transporter (Dai et al., 2017), which is the most abundant glucose
transporter in the brain (Jurcovicova, 2014), further investigation of glucose metabolism sex
differences is warranted. Additionally, the disparity in addictive behaviors between male and
female methamphetamine users signals a potential biological difference that may be of interest as
our understanding of addiction as a disease process is furthered.
This study aimed to use enzyme-based glucose biosensors and high-speed amperometry
to describe changes in extracellular glucose concentrations following acute intravenous
methamphetamine administration in doses that were behaviorally relevant low doses based off of
those seen in self-administration studies. Direct injections of glucose as well as saline were used
to determine baseline glucose concentrations in both males and females, test the integrity of the
sensor, and control for changes in glucose concentration due to the injection procedure itself. The
overall goal of this study was to determine differences in extracellular glucose concentrations in
the lateral hypothalamus following methamphetamine administration in a preclinical model
comparing male and female rats.
Methods
All experimental procedures involving the use of live animal subjects were approved by
the Institutional Animal Care and Use Committee (IACUC) at the University of Nebraska—
Lincoln.
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Animals
A cohort of age-matched male (N=17) and female (N=11) Wistar rats (Envigo) at
approximately 2.5 to 3 months, with males weighing 348.82 ± 6.06 g and females weighing
262.73 ± 6.89 g at the time of testing were used in this study. The female rats were intact and
free-cycling, and all rats were kept in group housing upon arrival in a climate-controlled animal
facility using filtered air cages. The rats were given unrestricted access to food and water, and
lights were cycled on a 12-12 schedule with the lights on at 15:00. Following the surgical
procedure detailed below, rats were isolated into a single cage so as to protect the implant. These
rats were still kept within sight and sound of other rats in the colony.
Surgery
Surgical procedures were performed under general anesthesia, induced using an
intraperitoneal injection of a combination of ketamine HCl (33 mg/kg) and xylazine (10mg/kg).
Anesthesia was then maintained using isoflurane (1-2%) delivered through a nose cone. The
incision areas for implantation were shaved and the rats were then placed in a stereotaxic frame.
The surgical procedure proceeded in two distinct stages, the first being the preparation of
the headstage and insertion of the BASi guide cannula. In order to enable implantation of the
cannula into the lateral hypothalamus, the skull was first exposed and cleaned which allowed for
the visualization of the bregma. Anterior-posterior (AP), medial-lateral (ML), and dorsal-ventral
(DV) stereotaxtic coordinates were then set to zero at the point of the bregma. A 1.0 mm hole
was then drilled into the skull and the guide cannula was lowered at a rate of approximately 0.05
mm/sec. The target coordinates for the lateral hypothalamus were AP -2.9 mm, ML +1.4 mm,
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and DV -7.2-7.6 mm, based on the Paxinos and Watson stereotaxic atlas (Franklin and Paxinos,
2006). An acrylic headstage was then prepared, anchored into the skull with three stainless steel
bone screws. This acrylic headstage served to secure multiple components of the experimental
setup, including the biosensor and cannula, the injection port, and the preamplifier.
In the second stage of the surgical procedure, rats were implanted with a chronic jugular
catheter (BTPU-040, Instech laboratories) that enabled direct injection of methamphetamine
through an injection port on the acrylic headstage. The patency of the injection port and jugular
catheter were continuously tested and maintained up to the experimentation day through daily
administration of 0.15-0.2 ml heparanized sterile saline with gentamycin (0.1 mg/ml).
Postoperative analgesia with carprofen (5 mg/kg) was established immediately following the
surgical procedure and maintained for two days. Rats were allowed a total of five days postoperative recovery prior to experimentation and data collection.
Drugs and injections
We dissolved (+)-(S)-methamphetamine HCl (a gift from the National Institutes on Drug
Abuse Drug Supply Program) in 0.9% sterile saline to prepare a stock solution of 0.05 mg/ml.
Methamphetamine was injected in a cumulative dosing schedule that accounts for the long halflife of methamphetamine, an approach commonly used in pharmacology studies (McGuire,
Baladi, and France, 2011). All doses of methamphetamine in mg/kg represent the weight of the
methamphetamine salt.
Experimentation and Data Collection
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A timeline of the data collection procedures is illustrated in Figure 1. Data collection
occurred following the five-day postoperative recovery. First, the glucose or null biosensor was
placed and secured into the cannula and the subjects subsequently placed into a semi-enclosed
chamber with bedding. A connection to the preamplifier, injection apparatus, and potentiostat
was established. In order to avoid damage to the layers of the biosensor or any other
experimental equipment, general anesthesia was induced and maintained for 2-3 minutes using
iosflurane for the implantation and connection of the biosensor, preamplifier, and syringe pump.
Rats were then allowed to habituate for approximately two hours prior to testing, which allowed
for the stabilization of baseline currents. Rats were first infused with one or two infusions of 250
μl 0.9% saline over 14.7 seconds, which enabled further assessment of sex differences in
baseline extracellular glucose concentrations as well as how the injection procedure itself may
influence changes in LH glucose levels.
Administration of the four cumulative doses of methamphetamine began 20 minutes after
the last saline injection. The doses delivered (0.025 mg/kg, 0.05 mg/kg, 0.1 mg/kg, 0.2 mg/kg)
were based off the range of doses typically seen in self-administration studies (McGuire, Baladi,
and France, 2011) . The methamphetamine solution was injected centrally using the syringe
pump into the jugular catheter. Doses of methamphetamine were spaced 55 minutes apart from
each other, and were injected at the same rate of 17 μL/second. In addition to the
methamphetamine injections, 60 mg of glucose in 0.6 mL of 0.9% sterile saline was delivered in
order to test the integrity of the biosensor and determine how rapidly changes in blood glucose
affect extracellular glucose in the lateral hypothalamus.
Data Analysis
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Electrochemical data from the glucose biosensor corresponding to LH glucose
concentrations was recorded using the Sirenia Acquisition suite (Pinnacle Technology). Relevant
timepoints were manually marked by experimenters during data collection. Raw data was
collected at 1 Hz, and following experimentation was exported as a text file and processed using
a custom Python script, which binned the data to either 2-s or 30-s, separated the annotated
events from each trial as well as identification, removal, and interpolation of outlier data based
on an inter-quartile range (IQR) that was selected for each stage of the experiment. Then, three
experimenters carefully examined the data to verify the automated processing and evaluate the
fidelity of the recording. Inclusion criteria required that all three raters reach a consensus that the
data was appropriate for further data analysis. A Mixed Effects Analysis of Variance (ANOVA)
was used to analyze the effect of sex and sex x time interactions on measured glucose
concentrations. Area under the curve (AUC) was employed to condense the magnitude of
glucose response over time into a single number for analysis. If the ANOVA revealed a
significant fixed effect or interaction, a Fisher post-hoc test was calculated to determine the
doses at which such an effect existed. The significance value was set at α = 0.05.
Results
Sex Differences in Baseline LH Glucose Concentration
To investigate sex differences in baseline glucose concentrations within the lateral
hypothalamus, I compared the glucose baselines between sexes throughout the entire recording
(Fig. 3).
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A two-way Mixed Effect ANOVA revealed no significant fixed effect of sex on glucose
baselines. However, there was a significant sex x time interaction (F7,119 =2.173 p= 0.0413) such
that the glucose baselines of the females had a decrease of greater magnitude compared to the
males. Additionally, baselines in both sexes decreased significantly over the duration of the
recording, F (7, 119) = 28.43, p < 0.0001.
Sex Differences in the Magnitude of LH Glucose Concentration Changes Following
Methamphetamine Administration at Differential Doses
A Two-way Mixed Effect ANOVA indicated a significant sex x time interaction, F (7, 119)
= 2.173, p = 0.0413, such that glucose concentration decreased more in females compared to
males following methamphetamine administration. Analysis of AUC indicates that the
magnitude of the glucose concentration change was greater in females at lower doses compared
to males, with a significant sex x dose interaction F (3,41) = 7.172, p = 0.0006. Post-hoc analysis
shows a significant sex difference at the 0.025 mg/kg dose.
Sex Differences in LH Glucose Concentrations at the Two Second Timescale in Response to
Intravenous Injections of Cumulative Doses of Methamphetamine
To examine sex differences in the rapid response of LH glucose concentrations to
cumulative doses of methamphetamine, I compared changes in LH glucose concentrations at a
two second resolution following each methamphetamine injection.
A Two-Way Mixed Effect ANOVA revealed that, at the rapid timescale, significant sex
differences existed during the first and second (0.025 mg/kg and 0.05 mg/kg, respectively)
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cumulative meth doses only. Specifically, the overall change in glucose concentration following
the 0.025 mg/kg injection varied by sex (F (1,16) = 5.00, p = 0.040), though there was no
significant sex x time interaction at this dose. At the 0.05 mg/kg dose, there was both a fixed
effect of sex (F (1, 17) = 6.71, p = 0.019) as well as a significant sex x time interaction (F (89,1513) =
2.58, p < 0.0001). Notably, the sex differences at the second dose were differentiated by those at
the first dose by their qualitative characteristics. Females showed a slight phasic increase to
15.97±9.15 µM following injection, then a decrease similar to the first injection. After
approximately 60s, the dynamic glucose concentration response in females shifted and glucose
concentrations began to increase. By contrast, glucose concentrations decreased to -41.90 ±
13.43 µM in males in a manner similar to the first injection— with no tonic or phasic increases
(Figure 4). No sex differences were seen at the 0.1 mg/kg or 0.2 mg/kg doses (third and fourth
injections, respectively).
Sex Differences in LH Glucose Concentrations at the 30 Second Timescale in Response to
Intravenous Injections of Cumulative Doses of Methamphetamine
To examine sex differences in the slow changes in LH glucose concentrations following
cumulative doses of methamphetamine, I compared changes in LH glucose concentrations at a
thirty second resolution following each methamphetamine injection.
A Two-Way Mixed Effect ANOVA revealed that, at the 30-second resolution, significant
sex differences were seen at the 0.025 mg/kg dose (F (1,14) = 6.90, p = 0.02, Figure 5a) and 0.2
mg/kg dose (F (1,14) = 5.62, p = 0.033, Figure 5d). Additionally, significant sex x time interactions
were seen at the 0.025 mg/kg (F (99,1386) = 1.527, p = 0.001, Figure 5a), 0.1 mg/kg (F (99,1485) =
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1.46, p = 0.003, Figure 5c), and 0.2 mg/kg (F (99,1386) = 6.85, p < 0.0001, Figure 5d) doses. No
sex differences were observed in the 0.05 mg/kg dose.
Discussion
The goal of this study was to determine differences in extracellular lateral hypothalamic
glucose concentrations following cumulative dosing of methamphetamine in a preclinical model
of male vs female rats. The data shows significant methamphetamine dose-dependent sex
differences at the rapid, two-second time scale as well as on the slow-change, 30 second
timescale. There were no significant fixed effects of sex on baseline glucose concentrations.
However, there was a significant sex x time interaction such that the change in glucose
concentrations over time was of greater magnitude in female subjects compared to male subjects.
Further, baselines significantly decreased in both sexes throughout experimentation.
Given that extracellular glucose levels are strongly linked to local blood flow in the brain
(Kiyatkin and Wakabayashi, 2015), it is important to consider the effects of methamphetamine
on cerebral blood vessels and blood flow. Methamphetamine primarily targets the dopamine
transporter and vesicular monoamine transporter proteins in the brain, leading to an overall
increase in dopaminergic transmission along the mesolimbic pathway (Völlm et al., 2004) which
the LH is connected to (McGinty et al., 2011). Prior research in dogs has shown that dopamine
stimulates α-adrenergic receptors and specific dopamine receptors in cerebral blood vessels.
Stimulation of specific dopamine receptors led to vasodilation, a response that dominated at
medium doses, while stimulation of α-adrenergic receptors led to a vasoconstriction response
that dominated at low doses as well as high doses (von Essen, 1974). These findings are further
corroborated by the results of the present study. First, my results show that extracellular glucose
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levels are strongly linked to blood glucose since a rise in extracellular glucose concentration was
seen following intravenous injection of glucose— directly supporting the findings of Kiatkin and
Wakabayashi, 2015. Using glucose concentration changes as a surrogate measure of blood flow
to the LH, my findings in female rats can be considered an extension of the results of von Essen,
1974. Specifically, at the medium dose of 0.1 mg/kg in females, extracellular glucose
concentrations increase prior to decreasing. However, at either low (0.025 mg/kg) or high (0.2
mg/kg) doses, and thus relatively low or high increases in dopamine transmission, extracellular
glucose concentrations decrease at a high magnitude. This suggests lower delivery of blood
glucose to the lateral hypothalamus.
The lack of prior studies providing consistent support for the findings in both sexes (e.g.
von Essex, 1974 is consistent only when considering the female cohort)— along with the
differential findings in the present study— implicate the hormonal physiology underlying sex
differences as a possible contributing factor. Sex hormones have been consistently implicated in
the regulation of cerebral blood flow (Crews and Khalil, 2001). Specifically, previous studies
have shown that estrogen increases global cerebral blood flow to the entire brain in human
females (Nevo, Soustiel, Thaler, 2007), and progesterone produces a corresponding increase in
peripheral blood flow (Molinari et al., 2001). Conversely, testosterone is known to suppress
vasodilation in the cerebrum of rats and, at lower concentrations, can provide a vasoconstrictive
effect (Gonzales, Krause, and Duckles, 2004).
Even though experimental evidence is limited by differences in methodology, species,
and cerebral regions studied, sex hormones persist as an evident factor in the complex regulation
of blood flow in the brain. However, despite the differential impacts sex hormones exhibit on
cerebral blood flow, there is no distinct pattern that can be observed given the existing
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experimental evidence. As such, the exact way sex hormones affect cerebral blood flow remains
an area in need of further investigation.
Along with the consideration of sex hormones having direct effects on cerebral blood
flow, my results can be further contextualized by previous findings highlighting general sex
differences in the LH neurons. In addition to being strongly connected with the mesolimbic
pathway (McGinty et al., 2011), neurons in the LH secreting orexin and MCH have been
implicated in regulation of activity of neurons in the NAc and other brain regions with known
direct involvement in addictive behaviors (DiLeone, Georgescu, and Nestler, 2003). The LH is
notable for its population of glucose-sensing neurons, including its MCH neurons, that adjust
firing rate based on the extracellular concentration of glucose (Burdakov, Luckman, and
Verkhratsky, 2005). Glucose-sensitive neurons in the LH become excited when K ATP channels
with Kir6.2 subunits close following ATP binding, which occurs at high levels with abundant
glucose in the extracellular space (Kong et al., 2010). Notably, studies investigating knockouts of
the Kir6.2 subunit have found significant sex differences in behaviors exhibited by knockout
mice (Deacon et al., 2006). This suggests potential sex-dependent differential functioning of the
receptor that is the fundamental basis for glucose-sensitivity in the LH. Because MCH neurons in
the LH are glucose-sensitive and play a role in addictive behaviors (DiLeone, Georgescu, and
Nestler, 2003), my findings showing differential glucose concentrations between sexes following
cumulative methamphetamine dosing highlights a potential role for this population of neurons in
the observed sex differences (by way of differential glucose sensing) as well as the possibility for
these differences in glucose concentrations to be implicated in the development of
methamphetamine addiction. However, there is not yet enough information to determine the
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exact role glucose concentrations may be playing in the development of addictive behaviors by
modulating MCH neurons in the LH, and thus further investigation into this area is needed.
Methamphetamine is a widely abused, highly addictive substance (Stoneberg, Shukla,
and Magness, 2017) and, as such, its properties as an addictive chemical should continue to be
studied. The present study contributes an understanding of how methamphetamine affects
glucose levels in the LH, a glucose-sensitive area of the brain implicated in addictive behaviors
(DiLeone, Georgescu, and Nestler, 2003). Further, this study highlights the sex-dependent effects
methamphetamine has on extracellular glucose levels in the LH. The sex differences discussed in
the present study can serve as the basis for further investigation into the mechanisms by which
methamphetamine addiction presents differently between sexes.
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Figure 1: The timeline of the experimentation day

Figure 2. Sex differences in baseline glucose changes with administration of 250 μL IV saline.
There were no significant differences in baseline extracellular glucose concentration changes in
the LH between males and females.

Running heading: SEX DIFFERENCES IN LH EC GLUCOSE DURING CUMULATIVE
DOSING OF METH IN RATS

22

Figure 3. Sex differences in (a) the glucose baseline and (b) area under the curve representing
magnitude of change in glucose concentration at each dose.
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Figure 4. Sex differences in the change in extracellular LH glucose concentration at a rapid
(2s) scale with (a) 250 μL saline, (b) 0.025 mg/kg methamphetamine, (c) 0.05 mg/kg
methamphetamine, (d) 0.1 mg/kg methamphetamine, and (e) 0.2 mg/kg methamphetamine.
Where there is both a graph of sex differences and a combined graph, no significant sex
differences were found.
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Figure 5. Sex differences in the change in extracellular LH glucose concentration at a slow
(30s) scale with (a) 0.025 mg/kg methamphetamine, (b) 0.05 mg/kg methamphetamine, (c) 0.1
mg/kg methamphetamine, and (d) 0.2 mg/kg methamphetamine

